img

Global Point of Care Testing for Infectious Disease Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Point of Care Testing for Infectious Disease Market Research Report 2024

According to MRAResearch’s new survey, global Point of Care Testing for Infectious Disease market is projected to reach US$ 13440 million in 2033, increasing from US$ 10280 million in 2022, with the CAGR of 10.0% during the period of 2023 to 2033.
Key companies engaged in the Point of Care Testing for Infectious Disease industry include Roche, Abbott, LifeScan, Siemens Healthineers, Danaher, Ascensia, BioMerieux, ARKRAY and Sinocare, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Point of Care Testing for Infectious Disease were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Point of Care Testing for Infectious Disease market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Point of Care Testing for Infectious Disease market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Roche
Abbott
LifeScan
Siemens Healthineers
Danaher
Ascensia
BioMerieux
ARKRAY
Sinocare
Wondfo
Yuwell
Runbio
KHB
Segment by Type
Immunological Test
Pathogen Nucleic Acid Test

Segment by Application


Hospital
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Point of Care Testing for Infectious Disease report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Point of Care Testing for Infectious Disease Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Immunological Test
1.2.3 Pathogen Nucleic Acid Test
1.3 Market by Application
1.3.1 Global Point of Care Testing for Infectious Disease Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Point of Care Testing for Infectious Disease Market Perspective (2018-2033)
2.2 Point of Care Testing for Infectious Disease Growth Trends by Region
2.2.1 Global Point of Care Testing for Infectious Disease Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Point of Care Testing for Infectious Disease Historic Market Size by Region (2018-2023)
2.2.3 Point of Care Testing for Infectious Disease Forecasted Market Size by Region (2024-2033)
2.3 Point of Care Testing for Infectious Disease Market Dynamics
2.3.1 Point of Care Testing for Infectious Disease Industry Trends
2.3.2 Point of Care Testing for Infectious Disease Market Drivers
2.3.3 Point of Care Testing for Infectious Disease Market Challenges
2.3.4 Point of Care Testing for Infectious Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Point of Care Testing for Infectious Disease Players by Revenue
3.1.1 Global Top Point of Care Testing for Infectious Disease Players by Revenue (2018-2023)
3.1.2 Global Point of Care Testing for Infectious Disease Revenue Market Share by Players (2018-2023)
3.2 Global Point of Care Testing for Infectious Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Point of Care Testing for Infectious Disease Revenue
3.4 Global Point of Care Testing for Infectious Disease Market Concentration Ratio
3.4.1 Global Point of Care Testing for Infectious Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Point of Care Testing for Infectious Disease Revenue in 2022
3.5 Point of Care Testing for Infectious Disease Key Players Head office and Area Served
3.6 Key Players Point of Care Testing for Infectious Disease Product Solution and Service
3.7 Date of Enter into Point of Care Testing for Infectious Disease Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Point of Care Testing for Infectious Disease Breakdown Data by Type
4.1 Global Point of Care Testing for Infectious Disease Historic Market Size by Type (2018-2023)
4.2 Global Point of Care Testing for Infectious Disease Forecasted Market Size by Type (2024-2033)
5 Point of Care Testing for Infectious Disease Breakdown Data by Application
5.1 Global Point of Care Testing for Infectious Disease Historic Market Size by Application (2018-2023)
5.2 Global Point of Care Testing for Infectious Disease Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Point of Care Testing for Infectious Disease Market Size (2018-2033)
6.2 North America Point of Care Testing for Infectious Disease Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Point of Care Testing for Infectious Disease Market Size by Country (2018-2023)
6.4 North America Point of Care Testing for Infectious Disease Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Point of Care Testing for Infectious Disease Market Size (2018-2033)
7.2 Europe Point of Care Testing for Infectious Disease Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Point of Care Testing for Infectious Disease Market Size by Country (2018-2023)
7.4 Europe Point of Care Testing for Infectious Disease Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Point of Care Testing for Infectious Disease Market Size (2018-2033)
8.2 Asia-Pacific Point of Care Testing for Infectious Disease Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Point of Care Testing for Infectious Disease Market Size by Region (2018-2023)
8.4 Asia-Pacific Point of Care Testing for Infectious Disease Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Point of Care Testing for Infectious Disease Market Size (2018-2033)
9.2 Latin America Point of Care Testing for Infectious Disease Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Point of Care Testing for Infectious Disease Market Size by Country (2018-2023)
9.4 Latin America Point of Care Testing for Infectious Disease Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Point of Care Testing for Infectious Disease Market Size (2018-2033)
10.2 Middle East & Africa Point of Care Testing for Infectious Disease Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Point of Care Testing for Infectious Disease Market Size by Country (2018-2023)
10.4 Middle East & Africa Point of Care Testing for Infectious Disease Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Point of Care Testing for Infectious Disease Introduction
11.1.4 Roche Revenue in Point of Care Testing for Infectious Disease Business (2018-2023)
11.1.5 Roche Recent Development
11.2 Abbott
11.2.1 Abbott Company Detail
11.2.2 Abbott Business Overview
11.2.3 Abbott Point of Care Testing for Infectious Disease Introduction
11.2.4 Abbott Revenue in Point of Care Testing for Infectious Disease Business (2018-2023)
11.2.5 Abbott Recent Development
11.3 LifeScan
11.3.1 LifeScan Company Detail
11.3.2 LifeScan Business Overview
11.3.3 LifeScan Point of Care Testing for Infectious Disease Introduction
11.3.4 LifeScan Revenue in Point of Care Testing for Infectious Disease Business (2018-2023)
11.3.5 LifeScan Recent Development
11.4 Siemens Healthineers
11.4.1 Siemens Healthineers Company Detail
11.4.2 Siemens Healthineers Business Overview
11.4.3 Siemens Healthineers Point of Care Testing for Infectious Disease Introduction
11.4.4 Siemens Healthineers Revenue in Point of Care Testing for Infectious Disease Business (2018-2023)
11.4.5 Siemens Healthineers Recent Development
11.5 Danaher
11.5.1 Danaher Company Detail
11.5.2 Danaher Business Overview
11.5.3 Danaher Point of Care Testing for Infectious Disease Introduction
11.5.4 Danaher Revenue in Point of Care Testing for Infectious Disease Business (2018-2023)
11.5.5 Danaher Recent Development
11.6 Ascensia
11.6.1 Ascensia Company Detail
11.6.2 Ascensia Business Overview
11.6.3 Ascensia Point of Care Testing for Infectious Disease Introduction
11.6.4 Ascensia Revenue in Point of Care Testing for Infectious Disease Business (2018-2023)
11.6.5 Ascensia Recent Development
11.7 BioMerieux
11.7.1 BioMerieux Company Detail
11.7.2 BioMerieux Business Overview
11.7.3 BioMerieux Point of Care Testing for Infectious Disease Introduction
11.7.4 BioMerieux Revenue in Point of Care Testing for Infectious Disease Business (2018-2023)
11.7.5 BioMerieux Recent Development
11.8 ARKRAY
11.8.1 ARKRAY Company Detail
11.8.2 ARKRAY Business Overview
11.8.3 ARKRAY Point of Care Testing for Infectious Disease Introduction
11.8.4 ARKRAY Revenue in Point of Care Testing for Infectious Disease Business (2018-2023)
11.8.5 ARKRAY Recent Development
11.9 Sinocare
11.9.1 Sinocare Company Detail
11.9.2 Sinocare Business Overview
11.9.3 Sinocare Point of Care Testing for Infectious Disease Introduction
11.9.4 Sinocare Revenue in Point of Care Testing for Infectious Disease Business (2018-2023)
11.9.5 Sinocare Recent Development
11.10 Wondfo
11.10.1 Wondfo Company Detail
11.10.2 Wondfo Business Overview
11.10.3 Wondfo Point of Care Testing for Infectious Disease Introduction
11.10.4 Wondfo Revenue in Point of Care Testing for Infectious Disease Business (2018-2023)
11.10.5 Wondfo Recent Development
11.11 Yuwell
11.11.1 Yuwell Company Detail
11.11.2 Yuwell Business Overview
11.11.3 Yuwell Point of Care Testing for Infectious Disease Introduction
11.11.4 Yuwell Revenue in Point of Care Testing for Infectious Disease Business (2018-2023)
11.11.5 Yuwell Recent Development
11.12 Runbio
11.12.1 Runbio Company Detail
11.12.2 Runbio Business Overview
11.12.3 Runbio Point of Care Testing for Infectious Disease Introduction
11.12.4 Runbio Revenue in Point of Care Testing for Infectious Disease Business (2018-2023)
11.12.5 Runbio Recent Development
11.13 KHB
11.13.1 KHB Company Detail
11.13.2 KHB Business Overview
11.13.3 KHB Point of Care Testing for Infectious Disease Introduction
11.13.4 KHB Revenue in Point of Care Testing for Infectious Disease Business (2018-2023)
11.13.5 KHB Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Point of Care Testing for Infectious Disease Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Immunological Test
Table 3. Key Players of Pathogen Nucleic Acid Test
Table 4. Global Point of Care Testing for Infectious Disease Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Point of Care Testing for Infectious Disease Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Point of Care Testing for Infectious Disease Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Point of Care Testing for Infectious Disease Market Share by Region (2018-2023)
Table 8. Global Point of Care Testing for Infectious Disease Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Point of Care Testing for Infectious Disease Market Share by Region (2024-2033)
Table 10. Point of Care Testing for Infectious Disease Market Trends
Table 11. Point of Care Testing for Infectious Disease Market Drivers
Table 12. Point of Care Testing for Infectious Disease Market Challenges
Table 13. Point of Care Testing for Infectious Disease Market Restraints
Table 14. Global Point of Care Testing for Infectious Disease Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Point of Care Testing for Infectious Disease Market Share by Players (2018-2023)
Table 16. Global Top Point of Care Testing for Infectious Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point of Care Testing for Infectious Disease as of 2022)
Table 17. Ranking of Global Top Point of Care Testing for Infectious Disease Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Point of Care Testing for Infectious Disease Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Point of Care Testing for Infectious Disease Product Solution and Service
Table 21. Date of Enter into Point of Care Testing for Infectious Disease Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Point of Care Testing for Infectious Disease Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Point of Care Testing for Infectious Disease Revenue Market Share by Type (2018-2023)
Table 25. Global Point of Care Testing for Infectious Disease Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Point of Care Testing for Infectious Disease Revenue Market Share by Type (2024-2033)
Table 27. Global Point of Care Testing for Infectious Disease Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Point of Care Testing for Infectious Disease Revenue Market Share by Application (2018-2023)
Table 29. Global Point of Care Testing for Infectious Disease Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Point of Care Testing for Infectious Disease Revenue Market Share by Application (2024-2033)
Table 31. North America Point of Care Testing for Infectious Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Point of Care Testing for Infectious Disease Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Point of Care Testing for Infectious Disease Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Point of Care Testing for Infectious Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Point of Care Testing for Infectious Disease Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Point of Care Testing for Infectious Disease Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Point of Care Testing for Infectious Disease Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Point of Care Testing for Infectious Disease Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Point of Care Testing for Infectious Disease Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Point of Care Testing for Infectious Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Point of Care Testing for Infectious Disease Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Point of Care Testing for Infectious Disease Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Point of Care Testing for Infectious Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Point of Care Testing for Infectious Disease Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Point of Care Testing for Infectious Disease Market Size by Country (2024-2033) & (US$ Million)
Table 46. Roche Company Detail
Table 47. Roche Business Overview
Table 48. Roche Point of Care Testing for Infectious Disease Product
Table 49. Roche Revenue in Point of Care Testing for Infectious Disease Business (2018-2023) & (US$ Million)
Table 50. Roche Recent Development
Table 51. Abbott Company Detail
Table 52. Abbott Business Overview
Table 53. Abbott Point of Care Testing for Infectious Disease Product
Table 54. Abbott Revenue in Point of Care Testing for Infectious Disease Business (2018-2023) & (US$ Million)
Table 55. Abbott Recent Development
Table 56. LifeScan Company Detail
Table 57. LifeScan Business Overview
Table 58. LifeScan Point of Care Testing for Infectious Disease Product
Table 59. LifeScan Revenue in Point of Care Testing for Infectious Disease Business (2018-2023) & (US$ Million)
Table 60. LifeScan Recent Development
Table 61. Siemens Healthineers Company Detail
Table 62. Siemens Healthineers Business Overview
Table 63. Siemens Healthineers Point of Care Testing for Infectious Disease Product
Table 64. Siemens Healthineers Revenue in Point of Care Testing for Infectious Disease Business (2018-2023) & (US$ Million)
Table 65. Siemens Healthineers Recent Development
Table 66. Danaher Company Detail
Table 67. Danaher Business Overview
Table 68. Danaher Point of Care Testing for Infectious Disease Product
Table 69. Danaher Revenue in Point of Care Testing for Infectious Disease Business (2018-2023) & (US$ Million)
Table 70. Danaher Recent Development
Table 71. Ascensia Company Detail
Table 72. Ascensia Business Overview
Table 73. Ascensia Point of Care Testing for Infectious Disease Product
Table 74. Ascensia Revenue in Point of Care Testing for Infectious Disease Business (2018-2023) & (US$ Million)
Table 75. Ascensia Recent Development
Table 76. BioMerieux Company Detail
Table 77. BioMerieux Business Overview
Table 78. BioMerieux Point of Care Testing for Infectious Disease Product
Table 79. BioMerieux Revenue in Point of Care Testing for Infectious Disease Business (2018-2023) & (US$ Million)
Table 80. BioMerieux Recent Development
Table 81. ARKRAY Company Detail
Table 82. ARKRAY Business Overview
Table 83. ARKRAY Point of Care Testing for Infectious Disease Product
Table 84. ARKRAY Revenue in Point of Care Testing for Infectious Disease Business (2018-2023) & (US$ Million)
Table 85. ARKRAY Recent Development
Table 86. Sinocare Company Detail
Table 87. Sinocare Business Overview
Table 88. Sinocare Point of Care Testing for Infectious Disease Product
Table 89. Sinocare Revenue in Point of Care Testing for Infectious Disease Business (2018-2023) & (US$ Million)
Table 90. Sinocare Recent Development
Table 91. Wondfo Company Detail
Table 92. Wondfo Business Overview
Table 93. Wondfo Point of Care Testing for Infectious Disease Product
Table 94. Wondfo Revenue in Point of Care Testing for Infectious Disease Business (2018-2023) & (US$ Million)
Table 95. Wondfo Recent Development
Table 96. Yuwell Company Detail
Table 97. Yuwell Business Overview
Table 98. Yuwell Point of Care Testing for Infectious Disease Product
Table 99. Yuwell Revenue in Point of Care Testing for Infectious Disease Business (2018-2023) & (US$ Million)
Table 100. Yuwell Recent Development
Table 101. Runbio Company Detail
Table 102. Runbio Business Overview
Table 103. Runbio Point of Care Testing for Infectious Disease Product
Table 104. Runbio Revenue in Point of Care Testing for Infectious Disease Business (2018-2023) & (US$ Million)
Table 105. Runbio Recent Development
Table 106. KHB Company Detail
Table 107. KHB Business Overview
Table 108. KHB Point of Care Testing for Infectious Disease Product
Table 109. KHB Revenue in Point of Care Testing for Infectious Disease Business (2018-2023) & (US$ Million)
Table 110. KHB Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Point of Care Testing for Infectious Disease Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Point of Care Testing for Infectious Disease Market Share by Type: 2022 VS 2033
Figure 3. Immunological Test Features
Figure 4. Pathogen Nucleic Acid Test Features
Figure 5. Global Point of Care Testing for Infectious Disease Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Point of Care Testing for Infectious Disease Market Share by Application: 2022 VS 2033
Figure 7. Hospital Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Point of Care Testing for Infectious Disease Report Years Considered
Figure 11. Global Point of Care Testing for Infectious Disease Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Point of Care Testing for Infectious Disease Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Point of Care Testing for Infectious Disease Market Share by Region: 2022 VS 2033
Figure 14. Global Point of Care Testing for Infectious Disease Market Share by Players in 2022
Figure 15. Global Top Point of Care Testing for Infectious Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point of Care Testing for Infectious Disease as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Point of Care Testing for Infectious Disease Revenue in 2022
Figure 17. North America Point of Care Testing for Infectious Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Point of Care Testing for Infectious Disease Market Share by Country (2018-2033)
Figure 19. United States Point of Care Testing for Infectious Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Point of Care Testing for Infectious Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Point of Care Testing for Infectious Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Point of Care Testing for Infectious Disease Market Share by Country (2018-2033)
Figure 23. Germany Point of Care Testing for Infectious Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Point of Care Testing for Infectious Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Point of Care Testing for Infectious Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Point of Care Testing for Infectious Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Point of Care Testing for Infectious Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Point of Care Testing for Infectious Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Point of Care Testing for Infectious Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Point of Care Testing for Infectious Disease Market Share by Region (2018-2033)
Figure 31. China Point of Care Testing for Infectious Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Point of Care Testing for Infectious Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Point of Care Testing for Infectious Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Point of Care Testing for Infectious Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Point of Care Testing for Infectious Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Point of Care Testing for Infectious Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Point of Care Testing for Infectious Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Point of Care Testing for Infectious Disease Market Share by Country (2018-2033)
Figure 39. Mexico Point of Care Testing for Infectious Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Point of Care Testing for Infectious Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Point of Care Testing for Infectious Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Point of Care Testing for Infectious Disease Market Share by Country (2018-2033)
Figure 43. Turkey Point of Care Testing for Infectious Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Point of Care Testing for Infectious Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Roche Revenue Growth Rate in Point of Care Testing for Infectious Disease Business (2018-2023)
Figure 46. Abbott Revenue Growth Rate in Point of Care Testing for Infectious Disease Business (2018-2023)
Figure 47. LifeScan Revenue Growth Rate in Point of Care Testing for Infectious Disease Business (2018-2023)
Figure 48. Siemens Healthineers Revenue Growth Rate in Point of Care Testing for Infectious Disease Business (2018-2023)
Figure 49. Danaher Revenue Growth Rate in Point of Care Testing for Infectious Disease Business (2018-2023)
Figure 50. Ascensia Revenue Growth Rate in Point of Care Testing for Infectious Disease Business (2018-2023)
Figure 51. BioMerieux Revenue Growth Rate in Point of Care Testing for Infectious Disease Business (2018-2023)
Figure 52. ARKRAY Revenue Growth Rate in Point of Care Testing for Infectious Disease Business (2018-2023)
Figure 53. Sinocare Revenue Growth Rate in Point of Care Testing for Infectious Disease Business (2018-2023)
Figure 54. Wondfo Revenue Growth Rate in Point of Care Testing for Infectious Disease Business (2018-2023)
Figure 55. Yuwell Revenue Growth Rate in Point of Care Testing for Infectious Disease Business (2018-2023)
Figure 56. Runbio Revenue Growth Rate in Point of Care Testing for Infectious Disease Business (2018-2023)
Figure 57. KHB Revenue Growth Rate in Point of Care Testing for Infectious Disease Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed